openPR Logo
Press release

Pharmacogenomics Market Size, Share, Development by 2024

02-26-2019 08:57 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Global Info Research

Pharmacogenomics Market Size, Share, Development by 2024

Global Info Research offers a latest published report on Pharmacogenomics Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 124 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.

Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/global-paediatric-sports-medicine-market_p104058.html
 
Pharmacogenomics is the study of the role of the genome in drug response. Its name reflects its combining of pharmacology and genomics. Pharmacogenomics analyzes how the genetic makeup of an individual affects his/her response to drugs.         

Scope of the Report:
This report studies the Pharmacogenomics (PGx) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Pharmacogenomics (PGx) market by product type and applications/end industries.

Market Segment by Companies, this report covers
    Abbott Laboratories
    Affymetrix, Inc.
    Assurex Health, Inc
    Astrazeneca
    GeneDX
    Illumina, Inc.
    Laboratory Corporation of America Holdings
    Myriad Genetics, Inc.
    Pathway Genomics
    Pfizer, Inc
    Qiagen, Inc.
    Rocheg
    Teva Pharmaceutical Industries Ltd.
    Thermo Fisher Scientific
    Transgenomic, Inc.

Market Segment by Type, covers
    Polymerase Chain Reaction (PCR)
    Microarray
    Sequencing
    Other

Market Segment by Applications, can be divided into
    Cardiovascular Diseases (CVD)
    Central Nervous System (CNS)
    Cancer/Oncology
    Infectious Diseases
    Other

For More Information On This Report, Please Visit @
https://www.globalinforesearch.com/global-paediatric-sports-medicine-market_p104058.html

Key Reasons to Purchase:
• To gain insightful analyses of the market and have a comprehensive understanding of the Pharmacogenomics Market and its commercial landscape.
• Learn about the market strategies that are being adopted by your competitors and leading organizations.
• To understand the future outlook and prospects for Pharmacogenomics Market analysis and forecast 2019- 2025.

Customization Service of the Report :
Global Info Research provides customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

About Us:
GlobalInfoResearch is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.

Contact US :
Global Info Research
E-mail: report@globalinforesearch.com
Tel: +86-13660489451 00852-58197708(HK)
Add: RM 1605C HO KING COMM CTR 2-16 FA YUEN ST MONGKOK KL Hong Kong
Website: http://www.globalinforesearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharmacogenomics Market Size, Share, Development by 2024 here

News-ID: 1616437 • Views:

More Releases from Global Info Research

Global Biological Mycotoxin Adsorbent Market Size, Market Share, Industry Analysis Report 2025
Global Biological Mycotoxin Adsorbent Market Size, Market Share, Industry Analys …
Global Info Research announces the release of the report "Global Biological Mycotoxin Adsorbent Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031" . The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets.
Reflective Roadline Paint Market: Sales Volume, Size, Share, Price Development Trend Forecast Report 2025-2031
Reflective Roadline Paint Market: Sales Volume, Size, Share, Price Development T …
On Oct 11, 2025, Global Info Research released a research report titled "Global Reflective Roadline Paint Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031". This report provides detailed data analysis of the Reflective Roadline Paint market from 2020 to 2031. Including the market size and development trends of Reflective Roadline Paint Market, it analyzes market size indicators such as sales, sales volume, average price and
Aqueous Wetting and Dispersing Additives Market Insights: Industry Opportunities, Drivers, Outlook and Trends Research Report
Aqueous Wetting and Dispersing Additives Market Insights: Industry Opportunities …
Global Info Research's report is a detailed and comprehensive analysis for global Aqueous Wetting and Dispersing Additives market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the Aqueous Wetting and Dispersing Additives market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets.
Water-based Epoxy Silane Oligomer Market Size, Competitor Ranking Analysis, Market Trend Forecast Report 2025-2031
Water-based Epoxy Silane Oligomer Market Size, Competitor Ranking Analysis, Mark …
Global Info Research's report offers key insights into the recent developments in the global Water-based Epoxy Silane Oligomer market that would help strategic decisions. It also provides a complete analysis of the market size, share, and potential growth prospects. Additionally, an overview of recent major trends, technological advancements, and innovations within the market are also included. Our report further provides readers with comprehensive insights and actionable analysis on the

All 5 Releases


More Releases for Pharmacogenomics

Pharmacogenomics - Top Companies Regional and Data Analysis
Pharmacogenomics is a branch of science, which studies the role of gene over the activity of a drugs and hence helps the refreshers in predicting the response of novel as well as previously available therapies. Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00007564/?utm_source=OpenPR&utm_medium=10129 Major Companies operating in the Pharmacogenomics Market are: • F. Hoffmann-la Roche Ltd • Abbott • Oxford Nanopore Technologies • Thermo Fisher Scientific Inc. • Illumina, Inc. • QIAGEN • Agilent Technologies, Inc. • Myriad Genetics, Inc. • Admera Health Contact Us: If you have any queries about
Pharmacogenomics Market worth $5.8 billion by 2028
North America region is witnessing increasing investments and research activities in the field of drug discovery and development. The need for advanced therapies due to rising rate of cancer has contributed to growth of the pharmacogenomics market. Pharmacogenomics Market [https://www.marketsandmarkets.com/Market-Reports/pharmacogenomics-market-142682251.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $5.8 billion by 2028, growing at a CAGR of 10.6% from 2023 to
Genetic Medicine: Unveiling the Power of Pharmacogenomics
Based on technology, the pharmacogenomics market is segmented into PCR, sequencing, microarray, gel electrophoresis, mass spectrometry, and others. The market for the PCR segment is subsegmented into real time PCR, standard PCR, and digital PCR. The PCR segment dominated the pharmacogenomics market in 2021 and is expected to register the highest CAGR during the forecast period. Download Sample PDF Details at: https://www.theinsightpartners.com/sample/TIPRE00007564?utm_source=OpenPR&utm_medium=10776 The pharmacogenomics market is segmented on the basis of
Complete PDF Guide On Pharmacogenomics [PDF]
According to our latest study on "Pharmacogenoics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Technology, Application, and End User," the market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is expected to grow at a CAGR of 10.3% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their
Global Pharmacogenomics Market Size & Trends
According to a new market research report published by Global Market Estimates, the global pharmacogenomics market is projected to grow at a CAGR of 9.6% from 2023 to 2028. The growth of the global pharmacogenomics market is driven by advancements in genomics and DNA sequencing technologies, the rising demand for personalized medicine, regulatory support from agencies like the FDA, cost-effectiveness through reduced adverse reactions, and a growing aging population with complex
Global Pharmacogenomics Services Market Insights | 2022-2032
The Pharmacogenomics Services Market refers to the services provided by companies and laboratories that offer personalized medicine based on a patient's genetic makeup. Pharmacogenomics is the study of how an individual's genes affect their response to certain drugs, and the pharmacogenomics services market focuses on utilizing this knowledge to optimize drug therapy. These services typically involve genetic testing to identify specific genetic variations that may impact a patient's response to certain